![](/img/cover-not-exists.png)
Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study
Tilly, Hervé, Morschhauser, Franck, Bartlett, Nancy L, Mehta, Amitkumar, Salles, Gilles, Haioun, Corinne, Munoz, Javier, Chen, Andy I, Kolibaba, Kathryn, Lu, Dan, Yan, Mark, Penuel, Elicia, Hirata, JaLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(19)30091-9
Date:
May, 2019
File:
PDF, 574 KB
english, 2019